ImmuCell
ICCC
26 hedge funds and large institutions have $5.03M invested in ImmuCell in 2022 Q4 according to their latest regulatory filings, with 1 funds opening new positions, 5 increasing their positions, 5 reducing their positions, and 1 closing their positions.
0.14% more ownership
Funds ownership: 12.53% → 12.67% (+0.14%)
0% more funds holding
Funds holding: 26 → 26 (0)
0% more first-time investments, than exits
New positions opened: 1 | Existing positions closed: 1
0% more repeat investments, than reductions
Existing positions increased: 5 | Existing positions reduced: 5
31% less capital invested
Capital invested by funds: $7.26M → $5.03M (-$2.24M)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Dimensional Fund Advisors
Austin,
Texas
|
+$286K |
| 2 |
Vanguard Group
Malvern,
Pennsylvania
|
+$26K |
| 3 |
Morgan Stanley
New York
|
+$20.2K |
| 4 |
TRCT
Tower Research Capital (TRC)
New York
|
+$9.21K |
| 5 |
BlackRock
New York
|
+$2.34K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
PP
Prosperity Planning
Kansas City,
Missouri
|
-$120K |
| 2 |
Renaissance Technologies
New York
|
-$87.3K |
| 3 |
PCM
Perritt Capital Management
Chicago,
Illinois
|
-$46.9K |
| 4 |
FHA
Flagship Harbor Advisors
Boston,
Massachusetts
|
-$14.4K |
| 5 |
Northern Trust
Chicago,
Illinois
|
-$1.6K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
26
Wells Fargo
San Francisco,
California
| $226 | – | – | – |
|
|
PP
27
Prosperity Planning
Kansas City,
Missouri
| – | -$120K | -16,000 | Closed |
|
ICCC Hedge Fund Activity: Q4 2022 in Review
26 of the 6,222 institutional investors tracked by Wall St. Rank reported a position in ImmuCell (ICCC) for Q4 2022, worth a combined $5.03M — down 31% from $7.26M a quarter earlier.
Fund positioning in ICCC was balanced in Q4 2022: 1 fund opened new positions, 1 closed out, 5 added to existing stakes and 5 trimmed.
The largest buyer was Dimensional Fund Advisors, adding an estimated $286K. The largest seller was Prosperity Planning, exiting entirely with an estimated $120K sold.
- 26 institutional investors held ImmuCell (ICCC) as of Q4 2022, unchanged from Q3 2022.
- Funds reported $5.03M of ImmuCell stock for Q4 2022, down 31% quarter-over-quarter.
- 1 fund opened new ImmuCell positions in Q4 2022 and 1 closed out, a net change of 0 holders.
- The largest ImmuCell buyer in Q4 2022 was Dimensional Fund Advisors, an estimated $286K added.
- The largest ImmuCell seller in Q4 2022 was Prosperity Planning, an estimated $120K sold.
Based on aggregated 13F filings for Q4 2022.